View Clinical Trial (Medical Research Study)

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation - NCT00412984-19713(Clinical Trial 157579)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Newark
State:  
DE
Zip Code: 19713
Conditions: Atrial Fibrillation - Atrial Flutter
Purpose: The trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner) is as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in subjects with atrial fibrillation and risk factors for stroke.
Study summary:
Criteria: Inclusion Criteria: - Males and females ≥ 18 yrs with AF and one or more of the following risk factors for stroke: - Age ≥ 75, previous stroke - TIA or Systemic Embolism - Symptomatic congestive heart failure or left ventricular dysfunction with LVEF ≤ 40% - Diabetes mellitus or hypertension requiring pharmacological treatment
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: May 21, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.